Yumi Kosaka Selected Research

Yumi Kosaka Research Topics

20	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 01/2020
13	Neoplasms (Cancer) 10/2022 - 01/2020
3	Thrombosis (Thrombus) 10/2021 - 10/2020
2	Liver Diseases (Liver Disease) 10/2021 - 10/2020
2	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2021
2	Microsatellite Instability 10/2020 - 07/2020
1	Proteinuria 08/2023
1	Cholangiocarcinoma 01/2022
1	Intrahepatic Cholestasis 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2021
1	Lung Neoplasms (Lung Cancer) 02/2021
1	Sclerosing Cholangitis 02/2021
1	Liver Failure 02/2021
1	Necrosis 01/2021
1	Fever (Fevers) 01/2021
1	Disease Progression 01/2020

12	lenvatinibIBA 09/2023 - 01/2020
6	Bevacizumab (Avastin)FDA Link 09/2023 - 08/2021
6	atezolizumabIBA 09/2023 - 08/2021
3	Sorafenib (BAY 43-9006)FDA Link 09/2023 - 10/2020
2	AlbuminsIBA 08/2023 - 10/2022
2	BilirubinIBA 08/2023 - 10/2022
2	Immune Checkpoint InhibitorsIBA 02/2021 - 10/2020
2	regorafenibIBA 01/2021 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	pembrolizumabIBA 10/2020 - 07/2020
1	CreatinineIBA 08/2023
1	Proteins (Proteins, Gene)FDA Link 08/2023
1	Serum AlbuminIBA 08/2023
1	Cisplatin (Platino)FDA LinkGeneric 06/2022
1	Nonsense Codon (Nonsense Mutation)IBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	EnzymesIBA 02/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2021
1	Prednisolone (Predate)FDA LinkGeneric 02/2021
1	NivolumabIBA 02/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2021
1	RamucirumabIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	AntigensIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020

14	Therapeutics 09/2023 - 01/2020
4	Drug Therapy (Chemotherapy) 06/2022 - 10/2020
3	Radiotherapy 10/2021 - 10/2020
1	Hepatectomy 01/2022
1	Fluid Therapy (Oral Rehydration Therapy) 10/2021
1	Stents 10/2021